Sarcoidosis (D86) ICD-10-CM
The D86 code range covers sarcoidosis with 15 ICD-10-CM diagnosis codes. 13 of them are billable and valid for claim submission in fiscal year 2026, and the category headers group them but cannot themselves be billed.
Codes in the D86 Range 15 codes · 13 billable
- D86 SarcoidosisNon-billable
- D86.0 Sarcoidosis of lung
- D86.1 Sarcoidosis of lymph nodes
- D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
- D86.3 Sarcoidosis of skin
- D86.8 Sarcoidosis of other sitesNon-billable
- D86.81 Sarcoid meningitis
- D86.82 Multiple cranial nerve palsies in sarcoidosis
- D86.83 Sarcoid iridocyclitis
- D86.84 Sarcoid pyelonephritis
- D86.85 Sarcoid myocarditis
- D86.86 Sarcoid arthropathy
- D86.87 Sarcoid myositis
- D86.89 Sarcoidosis of other sites
- D86.9 Sarcoidosis, unspecified
Clinical Terms in This Code Range
Definitions from the National Library of Medicine for conditions coded in the D86 range.
Dermatomyositis
A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
Mumps
An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)
Parotitis
INFLAMMATION of the PAROTID GLAND.
Polymyositis
Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
Rubulavirus
A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the species have hemagglutinin and neuraminidase activities but lack a C protein. MUMPS VIRUS is the type species.
Sarcoidosis
An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
Sarcoidosis, Pulmonary
Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
About the D86 Code Range
ICD-10 code D86 covers sarcoidosis, a condition characterized by the growth of inflammatory cell clusters in various organs. Specific codes under this section detail sarcoidosis based on the affected site, such as the lungs (D86.0), lymph nodes (D86.1), skin (D86.3), and other organs including the nervous system and heart.
The ICD-10 codes for sarcoidosis distinguish between different forms, helping coders and clinicians accurately document diagnoses. For instance, D86.0 is used for pulmonary sarcoidosis, often referred to as stages 1 through 4 pulmonary sarcoidosis or endobronchial sarcoidosis. D86.1 covers lymph node involvement like mediastinal or hilar lymphadenopathy. When both lung and lymph nodes are affected, D86.2 applies, including cases named Lofgren's syndrome. Skin sarcoidosis variants such as nodular, annular, or lupus pernio types use D86.3. Other specialized forms—like sarcoid meningitis (D86.81), cardiac involvement (sarcoid myocarditis, D86.85), or eye inflammation (sarcoid iridocyclitis, D86.83)—have dedicated codes. This specificity supports accurate clinical description and billing when sarcoidosis manifests in its many presentations.
Questions About This Page
How many billable codes are in the D86 range?
Of the 15 codes in this range, 13 are billable and valid for claim submission from October 1, 2025 through September 30, 2026. Category header codes group them but cannot be reported on claims.
What does the D86 range classify?
The range classifies sarcoidosis. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2026 ICD-10-CM Tabular List and order file, effective October 1, 2025 through September 30, 2026.
